Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Sørensen AL[au]:

Search results

Items: 1 to 50 of 57

1.

The red blood cell count and the erythrocyte sedimentation rate in the diagnosis of polycythaemia vera.

Nersesjan V, Zervides KA, Sørensen AL, Kjaer L, Skov V, Hasselbalch HC.

Eur J Haematol. 2019 Oct 4. doi: 10.1111/ejh.13334. [Epub ahead of print]

PMID:
31584701
2.

B-cell frequencies and immunoregulatory phenotypes in myeloproliferative neoplasms: Influence of ruxolitinib, interferon-α2, or combination treatment.

Sørensen AL, Bjørn ME, Riley CH, Holmstrøm M, Andersen MH, Svane IM, Mikkelsen SU, Skov V, Kjaer L, Hasselbalch HC, Nielsen CH.

Eur J Haematol. 2019 Oct;103(4):351-361. doi: 10.1111/ejh.13292. Epub 2019 Aug 18.

PMID:
31297883
3.

Prevalent cohort studies and unobserved heterogeneity.

Keiding N, Albertsen KL, Rytgaard HC, Sørensen AL.

Lifetime Data Anal. 2019 Oct;25(4):712-738. doi: 10.1007/s10985-019-09479-9. Epub 2019 Jul 3.

PMID:
31270651
4.

Statin treatment, oxidative stress and inflammation in a Danish population.

Sørensen AL, Hasselbalch HC, Nielsen CH, Poulsen HE, Ellervik C.

Redox Biol. 2019 Feb;21:101088. doi: 10.1016/j.redox.2018.101088. Epub 2018 Dec 21.

5.

JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation.

Czech J, Cordua S, Weinbergerova B, Baumeister J, Crepcia A, Han L, Maié T, Costa IG, Denecke B, Maurer A, Schubert C, Feldberg K, Gezer D, Brümmendorf TH, Müller-Newen G, Mayer J, Racil Z, Kubesova B, Knudsen T, Sørensen AL, Holmström M, Kjær L, Skov V, Larsen TS, Hasselbalch HC, Chatain N, Koschmieder S.

Leukemia. 2019 Apr;33(4):995-1010. doi: 10.1038/s41375-018-0295-6. Epub 2018 Nov 23.

PMID:
30470838
6.

Smoking is associated with increased risk of myeloproliferative neoplasms: A general population-based cohort study.

Pedersen KM, Bak M, Sørensen AL, Zwisler AD, Ellervik C, Larsen MK, Hasselbalch HC, Tolstrup JS.

Cancer Med. 2018 Nov;7(11):5796-5802. doi: 10.1002/cam4.1815. Epub 2018 Oct 14.

7.

Cardiovascular disease in chronic myelomonocytic leukemia: do monocytosis and chronic inflammation predispose to accelerated atherosclerosis?

Elbæk MV, Sørensen AL, Hasselbalch HC.

Ann Hematol. 2019 Jan;98(1):101-109. doi: 10.1007/s00277-018-3489-0. Epub 2018 Sep 4.

PMID:
30182347
8.

CL-L1 and CL-K1 Exhibit Widespread Tissue Distribution With High and Co-Localized Expression in Secretory Epithelia and Mucosa.

Hansen SWK, Aagaard JB, Bjerrum KB, Hejbøl EK, Nielsen O, Schrøder HD, Skjoedt K, Sørensen AL, Graversen JH, Henriksen ML.

Front Immunol. 2018 Jul 31;9:1757. doi: 10.3389/fimmu.2018.01757. eCollection 2018.

9.

Lamin A, Chromatin and FPLD2: Not Just a Peripheral Ménage-à-Trois.

Briand N, Cahyani I, Madsen-Østerbye J, Paulsen J, Rønningen T, Sørensen AL, Collas P.

Front Cell Dev Biol. 2018 Jul 9;6:73. doi: 10.3389/fcell.2018.00073. eCollection 2018. Review.

10.

Safety and efficacy of combination therapy of interferon-α2 and ruxolitinib in polycythemia vera and myelofibrosis.

Mikkelsen SU, Kjaer L, Bjørn ME, Knudsen TA, Sørensen AL, Andersen CBL, Bjerrum OW, Brochmann N, Fassi DE, Kruse TA, Larsen TS, Mourits-Andersen HT, Nielsen CH, Pallisgaard N, Thomassen M, Skov V, Hasselbalch HC.

Cancer Med. 2018 Aug;7(8):3571-3581. doi: 10.1002/cam4.1619. Epub 2018 Jun 22.

11.

Long-term visual outcome in a Danish population of patients with idiopathic intracranial hypertension.

Hatem CF, Yri HM, Sørensen AL, Wegener M, Jensen RH, Hamann S.

Acta Ophthalmol. 2018 Nov;96(7):719-723. doi: 10.1111/aos.13664. Epub 2018 Feb 6.

12.

Noninvasive measurement of reepithelialization and microvascularity of suction-blister wounds with benchmarking to histology.

Larsen HF, Ahlström MG, Gjerdrum LMR, Mogensen M, Ghathian K, Calum H, Sørensen AL, Forman JL, Vandeven M, Holerca MN, Du-Thumm L, Jorgensen LN, Ågren MS.

Wound Repair Regen. 2017 Nov;25(6):984-993. doi: 10.1111/wrr.12605. Epub 2018 Feb 16.

PMID:
29316016
13.

Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.

Christensen A, Kiss K, Lelkaitis G, Juhl K, Persson M, Charabi BW, Mortensen J, Forman JL, Sørensen AL, Jensen DH, Kjaer A, von Buchwald C.

BMC Cancer. 2017 Aug 25;17(1):572. doi: 10.1186/s12885-017-3563-3.

14.

A lipodystrophy-causing lamin A mutant alters conformation and epigenetic regulation of the anti-adipogenic MIR335 locus.

Oldenburg A, Briand N, Sørensen AL, Cahyani I, Shah A, Moskaug JØ, Collas P.

J Cell Biol. 2017 Sep 4;216(9):2731-2743. doi: 10.1083/jcb.201701043. Epub 2017 Jul 27.

15.

Macrophage migration inhibitory factor (MIF) modulates trophic signaling through interaction with serine protease HTRA1.

Fex Svenningsen Å, Löring S, Sørensen AL, Huynh HUB, Hjæresen S, Martin N, Moeller JB, Elkjær ML, Holmskov U, Illes Z, Andersson M, Nielsen SB, Benedikz E.

Cell Mol Life Sci. 2017 Dec;74(24):4561-4572. doi: 10.1007/s00018-017-2592-z. Epub 2017 Jul 19.

16.

Suction blister lesions and epithelialization monitored by optical coherence tomography.

Ahlström MG, Gjerdrum LMR, Larsen HF, Fuchs C, Sørensen AL, Forman JL, Ågren MS, Mogensen M.

Skin Res Technol. 2018 Feb;24(1):65-72. doi: 10.1111/srt.12391. Epub 2017 Jul 7.

PMID:
28685861
17.

Chrom3D: three-dimensional genome modeling from Hi-C and nuclear lamin-genome contacts.

Paulsen J, Sekelja M, Oldenburg AR, Barateau A, Briand N, Delbarre E, Shah A, Sørensen AL, Vigouroux C, Buendia B, Collas P.

Genome Biol. 2017 Jan 30;18(1):21. doi: 10.1186/s13059-016-1146-2.

18.

[Denosumab may be a supplement to the surgical treatment of giant cell tumours of bone].

Sørensen AL, Hansen RL, Jørgensen PH.

Ugeskr Laeger. 2016 Sep 5;178(36). pii: V03160204. Review. Danish.

PMID:
27593237
19.

A remarkable hematological and molecular response pattern in a patient with polycythemia vera during combination therapy with simvastatin and alendronate.

Sørensen AL, Kallenbach K, Hasselbalch HC.

Leuk Res Rep. 2016 Jun 27;6:20-3. doi: 10.1016/j.lrr.2016.06.004. eCollection 2016.

20.

Second malignancies in hydroxyurea and interferon-treated Philadelphia-negative myeloproliferative neoplasms.

Hansen IO, Sørensen AL, Hasselbalch HC.

Eur J Haematol. 2017 Jan;98(1):75-84. doi: 10.1111/ejh.12787. Epub 2016 Sep 4.

PMID:
27471124
21.

Chronic inflammation and autoimmunity as risk factors for the development of chronic myelomonocytic leukemia?

Elbæk MV, Sørensen AL, Hasselbalch HC.

Leuk Lymphoma. 2016 Aug;57(8):1793-9. doi: 10.3109/10428194.2016.1143938. Epub 2016 Feb 16.

PMID:
26879691
22.

Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms.

Sørensen AL, Hasselbalch HC.

Leuk Res. 2016 Feb;41:27-35. doi: 10.1016/j.leukres.2015.11.017. Epub 2015 Dec 2.

PMID:
26718091
23.

Genome-wide analysis of DNA methylation and gene expression patterns in purified, uncultured human liver cells and activated hepatic stellate cells.

El Taghdouini A, Sørensen AL, Reiner AH, Coll M, Verhulst S, Mannaerts I, Øie CI, Smedsrød B, Najimi M, Sokal E, Luttun A, Sancho-Bru P, Collas P, van Grunsven LA.

Oncotarget. 2015 Sep 29;6(29):26729-45. doi: 10.18632/oncotarget.4925.

24.

[Gruppe G streptococci as a rare cause of nosocomial post-partum infection].

Jöhnk ML, Ingels HA, Sørensen AL, Lambertsen L.

Ugeskr Laeger. 2013 Mar 11;175(11):740-1. Danish.

PMID:
23480889
25.

Carbohydrate clearance receptors in transfusion medicine.

Sørensen AL, Clausen H, Wandall HH.

Biochim Biophys Acta. 2012 Nov;1820(11):1797-808. doi: 10.1016/j.bbagen.2012.07.008. Epub 2012 Jul 27. Review.

PMID:
22846227
26.

The origin and function of platelet glycosyltransferases.

Wandall HH, Rumjantseva V, Sørensen AL, Patel-Hett S, Josefsson EC, Bennett EP, Italiano JE Jr, Clausen H, Hartwig JH, Hoffmeister KM.

Blood. 2012 Jul 19;120(3):626-35. doi: 10.1182/blood-2012-02-409235. Epub 2012 May 21.

27.

Dysregulation of CD4+CD25+CD127lowFOXP3+ regulatory T cells in HIV-infected pregnant women.

Kolte L, Gaardbo JC, Karlsson I, Sørensen AL, Ryder LP, Skogstrand K, Ladelund S, Nielsen SD.

Blood. 2011 Feb 10;117(6):1861-8. doi: 10.1182/blood-2010-07-298992. Epub 2010 Dec 16.

PMID:
21163930
28.

[Patient safety in a health technology assessment perspective].

Jensen HI, Christensen M, Hansen MD, Jørgensen SJ, Sørensen AL, Mainz J.

Ugeskr Laeger. 2010 May 24;172(21):1606-9. Danish.

PMID:
20525474
29.

Promoter DNA methylation patterns of differentiated cells are largely programmed at the progenitor stage.

Sørensen AL, Jacobsen BM, Reiner AH, Andersen IS, Collas P.

Mol Biol Cell. 2010 Jun 15;21(12):2066-77. doi: 10.1091/mbc.E10-01-0018. Epub 2010 Apr 21.

30.

Chromatin environment of histone variant H3.3 revealed by quantitative imaging and genome-scale chromatin and DNA immunoprecipitation.

Delbarre E, Jacobsen BM, Reiner AH, Sørensen AL, Küntziger T, Collas P.

Mol Biol Cell. 2010 Jun 1;21(11):1872-84. doi: 10.1091/mbc.E09-09-0839. Epub 2010 Apr 7. Erratum in: Mol Biol Cell. 2010 Nov;21(21):3759.

31.

Lineage-specific promoter DNA methylation patterns segregate adult progenitor cell types.

Sørensen AL, Timoskainen S, West FD, Vekterud K, Boquest AC, Ahrlund-Richter L, Stice SL, Collas P.

Stem Cells Dev. 2010 Aug;19(8):1257-66. doi: 10.1089/scd.2009.0309.

PMID:
19886822
32.

Dual roles for hepatic lectin receptors in the clearance of chilled platelets.

Rumjantseva V, Grewal PK, Wandall HH, Josefsson EC, Sørensen AL, Larson G, Marth JD, Hartwig JH, Hoffmeister KM.

Nat Med. 2009 Nov;15(11):1273-80. doi: 10.1038/nm.2030. Epub 2009 Sep 27.

33.

Improved thymic index, density and output in HIV-infected patients following low-dose growth hormone therapy: a placebo controlled study.

Hansen BR, Kolte L, Haugaard SB, Dirksen C, Jensen FK, Ryder LP, Sørensen AL, Flyvbjerg A, Nielsen SD, Andersen O.

AIDS. 2009 Oct 23;23(16):2123-31. doi: 10.1097/QAD.0b013e3283303307.

PMID:
19625946
34.

Immunoprecipitation of methylated DNA.

Sørensen AL, Collas P.

Methods Mol Biol. 2009;567:249-62. doi: 10.1007/978-1-60327-414-2_16. Review.

PMID:
19588097
35.

Role of sialic acid for platelet life span: exposure of beta-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor-expressing liver macrophages and hepatocytes.

Sørensen AL, Rumjantseva V, Nayeb-Hashemi S, Clausen H, Hartwig JH, Wandall HH, Hoffmeister KM.

Blood. 2009 Aug 20;114(8):1645-54. doi: 10.1182/blood-2009-01-199414. Epub 2009 Jun 11.

36.

Glycans and glycosylation of platelets: current concepts and implications for transfusion.

Sørensen AL, Hoffmeister KM, Wandall HH.

Curr Opin Hematol. 2008 Nov;15(6):606-11. doi: 10.1097/MOH.0b013e328313e3bd. Review.

PMID:
18832932
37.

[Treatment of idiopathic hypereosinophilic syndrome with imatinib].

Sørensen AL, Larsen H.

Ugeskr Laeger. 2008 Jan 21;170(4):254. Danish.

PMID:
18282461
38.

Epigenetic Basis for the Differentiation Potential of Mesenchymal and Embryonic Stem Cells.

Collas P, Noer A, Sørensen AL.

Transfus Med Hemother. 2008;35(3):205-215. Epub 2008 May 8.

39.

Galactosylation does not prevent the rapid clearance of long-term, 4 degrees C-stored platelets.

Wandall HH, Hoffmeister KM, Sørensen AL, Rumjantseva V, Clausen H, Hartwig JH, Slichter SJ.

Blood. 2008 Mar 15;111(6):3249-56. Epub 2007 Dec 20.

PMID:
18096766
40.
41.

Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.

Tarp MA, Sørensen AL, Mandel U, Paulsen H, Burchell J, Taylor-Papadimitriou J, Clausen H.

Glycobiology. 2007 Feb;17(2):197-209. Epub 2006 Oct 18.

PMID:
17050588
42.
43.

Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.

Sørensen AL, Reis CA, Tarp MA, Mandel U, Ramachandran K, Sankaranarayanan V, Schwientek T, Graham R, Taylor-Papadimitriou J, Hollingsworth MA, Burchell J, Clausen H.

Glycobiology. 2006 Feb;16(2):96-107. Epub 2005 Oct 5.

PMID:
16207894
44.

Induction of dedifferentiation, genomewide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells.

Taranger CK, Noer A, Sørensen AL, Håkelien AM, Boquest AC, Collas P.

Mol Biol Cell. 2005 Dec;16(12):5719-35. Epub 2005 Sep 29.

45.

Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1B.

Andersen HS, Olsen OH, Iversen LF, Sørensen AL, Mortensen SB, Christensen MS, Branner S, Hansen TK, Lau JF, Jeppesen L, Moran EJ, Su J, Bakir F, Judge L, Shahbaz M, Collins T, Vo T, Newman MJ, Ripka WC, Møller NP.

J Med Chem. 2002 Sep 26;45(20):4443-59.

PMID:
12238924
46.

Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis.

Sørensen AL, Nagai S, Houen G, Andersen P, Andersen AB.

Infect Immun. 1995 May;63(5):1710-7.

47.

Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice.

Andersen P, Andersen AB, Sørensen AL, Nagai S.

J Immunol. 1995 Apr 1;154(7):3359-72.

PMID:
7897219
48.
49.

Thioxanthenes inhibit multiplication of Leishmania major and its attachment to human monocytes in vitro.

Sørensen AL, Nielsen H, Kharazmi A.

Acta Trop. 1993 Mar;53(1):73-7. No abstract available.

PMID:
8096111
50.

Activation of human T lymphocytes by Leishmania lipophosphoglycan.

Kemp M, Theander TG, Handman E, Hey AS, Kurtzhals JA, Hviid L, Sørensen AL, Were JO, Koech DK, Kharazmi A.

Scand J Immunol. 1991 Feb;33(2):219-24.

PMID:
1902000

Supplemental Content

Loading ...
Support Center